Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback